¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"secondary anemia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • isoimmune hemolytic anemia
    µ¿Á¾¸é¿ª¿ëÇ÷ºóÇ÷
  • immunohemolytic anemia
    ¸é¿ª¿ëÇ÷ºóÇ÷
  • idiopathic anemia
    Ư¹ßºóÇ÷
  • leukoerythroblastic anemia
    ¹éÀûÇ÷¸ð±¸ºóÇ÷
  • lactation anemia
    ¼öÀ¯ºóÇ÷
  • miner¡¯s anemia
    ±¤ºÎºóÇ÷
  • malignant anemia
    ¾Ç¼ººóÇ÷
  • mountain anemia
    °í»êºóÇ÷
  • macrocytic anemia
    Å«ÀûÇ÷±¸ºóÇ÷, ´ëÀûÇ÷±¸ºóÇ÷
  • megaloblastic anemia
    °Å´ëÀûÇ÷¸ð±¸ºóÇ÷
  • megalocytic anemia
    °Å´ëÀûÇ÷±¸ºóÇ÷
  • microangiopathic hemolytic anemia
    ¹Ì¼¼Ç÷°üº´Áõ¿ëÇ÷ºóÇ÷
  • microcytic anemia
    ÀÛÀºÀûÇ÷±¸ºóÇ÷, ¼ÒÀûÇ÷±¸ºóÇ÷
  • microdrepanocytic anemia
    ÀÛÀº³´ÀûÇ÷±¸ºóÇ÷
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • megalocytic anemia
    °Å´ëÀûÇ÷±¸ºóÇ÷
  • microangiopathic hemolytic anemia
    ¹Ì¼¼Ç÷°üº´¿ëÇ÷ºóÇ÷
  • microcytic anemia
    ¼ÒÀûÇ÷±¸ºóÇ÷
  • microdrepanocytic anemia
    ÀÛÀº³´ÀûÇ÷±¸ºóÇ÷
  • miner's anemia
    ±¤ºÎºóÇ÷
  • mountain anemia
    °í»êºóÇ÷
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • normoblastic refractory anemia
    Á¤»óÀûÇ÷¸ð±¸Áö¿¬¹ÝÀÀºóÇ÷
  • normochromic anemia
    Á¤»ó»ö¼ÒºóÇ÷
  • normochromic unresponsive anemia
    Á¤»ó»ö¼ÒÁö¿¬¹ÝÀÀºóÇ÷
  • normocytic anemia
    Á¤»óÀûÇ÷±¸ºóÇ÷
  • normovolemic anemia
    Á¤»óÇ÷·®ºóÇ÷
  • pernicious anemia
    ¾Ç¼ººóÇ÷
  • physiological anemia
    »ý¸®ÀûºóÇ÷
  • posthemorrhagic anemia
    ÃâÇ÷ÈĺóÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hypochromic anemia
    Ç÷»ö¼Ò°¨¼Ò(¼º)ºóÇ÷
  • hypochromic microcytic anemia
    Àú»ö¼Ò¼º ¼Ò±¸¼º ºóÇ÷(¡­á´Ï¹àõÞ¸úì).
  • hypochromic microcytic anemia
    Àú»ö¼Ò¼º¼Ò±¸¼ººóÇ÷(î¸ßäáÈàõá³Ï¹àõÞ¸úì)
  • hypochromic microcytic anemia
    Àú»ö¼Ò¼º ¼Ò±¸¼º ºóÇ÷(?ËÛË´ËÛË×Ì´).
  • hypochrosis =hypochromic anemia
    Àú»ö¼ÒÁõ, Ç÷»ö¼Ò°¨¼Ò¼º ºóÇ÷.
  • immune cause (hemolytic anemia)
    ¸é¿ª¿øÀÎ(¿ëÇ÷¼ººóÇ÷)
  • immune hemolytic anemia
    ¸é¿ª¿ëÇ÷¼º ºóÇ÷
  • immune incompatibility (hemolytic anemia)
    ¸é¿ªºÎÀûÇÕ(¿ëÇ÷¼ººóÇ÷)
  • immunohemolytic anemia
    ¸é¿ª¿ëÇ÷¼ººóÇ÷(Øóæ¹éÁúìàõÞ¸úì)
  • infectious anemia
    °¨¿°¼º ºóÇ÷.
  • physiological anemia
    »ý¸®Àû ºóÇ÷(¡­Þ¸úì).
  • pleochromic anemia
    ´Ù»ö¼º ºóÇ÷(Òýßäàõ Þ¸úì)
  • poikilocytic anemia
    º¯Çü<ÀÌÇü>ÀûÇ÷±¸¼º ºóÇ÷.
  • poikilocytic anemia
    º¯Çü<ÀÌÇü>ÀûÇ÷±¸¼ººóÇ÷(ܨû¡<ì¶û¡>îåúìϹàõÞ¸úì)
  • posthemorrhagic anemia
    ÃâÇ÷ÈĺóÇ÷(¡­Þ¸úì), ÃâÇ÷¼º ºóÇ÷.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • secondary contracted kindney
    ÀÌÂ÷¼º À§Ãà½Å(¡­ê×õêãì)
  • secondary cyst
    ÀÌÂ÷³¶(ì£ó­Ò¥)
  • secondary dentin
    ÀÌÂ÷»ó¾ÆÁú
  • secondary dentine
    Á¦ÀÌ»ó¾ÆÁú(¡­ßÚä³òõ).
  • secondary dentition
    Á¦ÀÌ»ýÄ¡(¡­ßæöÍ).
  • secondary dermal ridge
    ÀÌÂ÷ÁøÇǸª(ì£ó­òØù«×Ò)
  • secondary deviation
    Á¦ÀÌÆíÀ§
  • secondary disease
    ¼Ó¹ßÁõ(áÙÛ¡ñø)
  • secondary dysmenorrhea
    2Â÷¼º(¼Ó¹ß¼º(áÙÛ¡àõ))¿ù °æ°ï¶õÁõ(êÅÌèÍÝÑññø), 2Â÷¼º¿ù°æÅë.
  • secondary dysmenorrhea
    ÈÄõ¼º ¿ù°æ°ï¶õ(Áõ)(ý­ô¸àõêÅÌèÍÝÑññø), ÀÌÂ÷¼º ¿ù°æ°ï¶õ(Áõ)(ì£ó­àõ¡­)
  • secondary efflorescence
    ¼Ó¹ßÁø(áÙÛ¡òÖ)
  • secondary elaboration
    ÀÌÂ÷ÇÕ¼º
  • secondary electron
    ÀÌÂ÷ÀüÀÚ.
  • secondary enamel cuticle
    ÀÌÂ÷¹ý³¶Áú¼ÒÇÇ(ì£ó­¡­á³ù«)
  • secondary ending
    ÀÌÂ÷Á¾¸»(ì£ó­ðûØÇ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SIMS secondary ion mass spectroscopy
SL sarcolemma; sclerosing leukoencephalopathy; secondary leukemia; segment length; sensation level; sen...
SMDS secondary myelodysplastic syndrome
SPH secondary pulmonary hemosiderosis; severely and profoundly handicapped; spherocyte; spherocytosis; s...
SSAA sicca syndrome associated antigen A; Sjogren syndrome-associated antigen A; syringomyelia secondary ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
IDA Iron Deficiency Anemia
MAHA Microangiopathic hemolytic anemia
RAEB-T Refractory anemia with excess blasts in transformation
RARS Refractory anemia with ringed sideroblasts
TRMA Thiamine responsive megaloblastic anemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • megaloblastic anemia
    °Å´ë Àû¾Æ±¸¼º ºóÇ÷
    °ñ¼ö¿¡ °Å´ë Àû¾Æ±¸°¡ ³ªÅ¸³ª´Â °ÍÀÌ Æ¯Â¡ÀÎ ºóÇ÷.
  • microangiopathic anemia
    ¹Ì¼¼ Ç÷°üº´¼º ºóÇ÷
  • microangiopathic hemolytic anemia
    ¹Ì¼¼ Ç÷°üº´¼º ¿ëÇ÷¼º ºóÇ÷
  • microcytic anemia
    ¼Ò±¸¼º ºóÇ÷
  • microdrepanocytic anemia
    ¼Ò °â»ó ÀûÇ÷±¸¼º ºóÇ÷
  • mountain anemia
    »ê¾Ç ºóÇ÷
  • normochromic anemia
    Á¤»ö¼Ò¼º ºóÇ÷, Á¤ÀûÇ÷±¸¼º ºóÇ÷
  • normocytic and normochromic anemia
    Á¤ÀûÇ÷±¸¼º ºóÇ÷
  • osteosclerotic anemia
    °ñ °æÈ­¼º ºóÇ÷
  • pernicious anemia
    ¾Ç¼º ºóÇ÷
    Ç÷¾× ¼Ó¿¡ °Å´ë Àû¾Æ±¸, °Å´ë ÀûÇ÷±¸°¡ ´Ù¼ö ³ªÅ¸³ª´Â ºóÇ÷·Î¼­ ¼Ò¾Æ¿¡°Ôµµ ³ªÅ¸³ªÁö¸¸ ÀϹÝÀûÀ¸·Î ¼ºÀο¡°Ô ³ªÅ¸³ª¸ç, È÷½ºÅ¸¹Î ³»¼ºÀÇ À§»ê °áÇÌÁõÀ» Ư¡À¸·Î ÇÑ´Ù. ÀÌ °æ¿ì¿¡ °Ë»ç ¼Ò°ß°ú ÀÓ»ó Áõ»óÀº À§ Á¡¸·ÀÌ ÀûÀýÇϰí À¯È¿ÇÑ ³»ÀÎÀÚ¸¦ ºÐºñÇÏÁö ¸øÇÏ¿© ºñŸ¹Î B12°¡ Àß Èí¼öµÇÁö ¸øÇÏ´Â °ÍÀÌ ±Ùº» ¿øÀÎÀÌ´Ù.
  • physiological anemia
    »ý¸®Àû ºóÇ÷
  • poikilocytic anemia
    º¯Çü ÀûÇ÷±¸¼º ºóÇ÷, ÀÌÇü ÀûÇ÷±¸¼º ºóÇ÷
  • sickle cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯Àü¼ºÀÇ ¿ëÇ÷¼º ºóÇ÷·Î¼­ ÀÌ»ó Ç÷»ö¼ÒÁõÀÇ ÇϳªÀ̸ç ÈæÀο¡°Ô¼­ ÁÖ·Î ³ªÅ¸³ª°í Ç÷¾×¿¡ °â»ó ÀûÇ÷±¸°¡ ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • sickle-cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯ÀüÀûÀ¸·Î Çì¸ð±Û·Îºó º£Å¸ ±Û·Îºó chainÀÌ valineÀ¸·Î ¹Ù²î¾î ³´ ¸ð¾çÀÇ ÀûÇ÷±¸¸¦ »ý¼ºÇÏ´Â »óÅÂ. ÈæÀο¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù.
  • sideroblastic refractory anemia
    ö Àû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
secondary hypogammaglobulinaemia Immunodeficiency in which there is no evident defect in the lymphoid tissues, but rather hypercatabolism or loss of immunoglobulins such as occurs in familial idiopathic hypercatabolic hypoproteinaemia or in defects associated with the nephrotic syndrome.
Synonym: secondary agammaglobulinaemia, secondary antibody deficiency, secondary hypogammaglobulinaemia.
(05 Mar 2000)
secondary hypogonadism Defective gonadal development or function, or both, resulting from inadequate secretion of pituitary gonadotropins.
Synonym: hypogonadotropic eunuchoidism, secondary hypogonadism.
(05 Mar 2000)
secondary hypothyroidism Hypothyroidism that arises as a consequence of inadequate thyrotropin secretion by the anterior pituitary gland.
(05 Mar 2000)
secondary immune response The response of the immune system to the second or subsequent occasion on which it encounters a specific antigen.
(18 Nov 1997)
secondary immunodeficiency Immunodeficiency in which there is no evident defect in the lymphoid tissues, but rather hypercatabolism or loss of immunoglobulins such as occurs in familial idiopathic hypercatabolic hypoproteinaemia or in defects associated with the nephrotic syndrome.
Synonym: secondary agammaglobulinaemia, secondary antibody deficiency, secondary hypogammaglobulinaemia.
(05 Mar 2000)
secondary infection An infection, usually septic, occurring in a person or animal already suffering from an infection of another nature.
(05 Mar 2000)
secondary interatrial foramen A secondary opening appearing in the upper part of the septum primum in the sixth week of embryonic life, just prior to the closure of the interatrial foramen primum.
Synonym: ostium secundum, secondary interatrial foramen.
(05 Mar 2000)
secondary leukaemia A leukaemia arising from either previous chemotherapy or radiotherapy or as the development of a pre-existing condition, such as myelodysplasia.
Origin: Gr. Haima = blood
(13 Nov 1997)
secondary lung cancer The spread of cancerous tumours from a distant organ to the lung. Due to the lungs tremendous blood and lymphatic supply it is a frequent site for metastatic cancer. Cancers which commonly metastasize to the lung include osteosarcoma, breast cancer, neuroblastoma, Wilm's tumour and non-Hodgkin's lymphomas.
(27 Sep 1997)
secondary lymphoid tissue <anatomy> Tissue that is particularly rich in lymphocytes (and accessory cells such as macrophages and reticular cells), particularly the lymph nodes, spleen, thymus, Peyer's patches, pharyngeal tonsils, adenoids and (in birds) the Bursa of Fabricius.
Central lymphoid tissue: A term occasionally used as synonym for primary lymphoid tissue but should be avoided to prevent confusion between anatomical location, which is irrelevant and centrality in the system.
Peripheral lymphoid tissue: Secondary lymphoid tissue, not necessarily located peripherally.
Primary lymphoid tissue: Lymphoid tissues in which immune cells develop as opposed to the secondary or peripheral lymphoid tissues in which antigen independent or antigen dependent stages of maturation take place and in which responsive lymphocytes are found. Primary lymphoid tissues are foetal liver, adult bone marrow and thymus (and Bursa of Fabricius in birds). Secondary tissues are lymph nodes, spleen, tonsils and mucosa associated lymphoid tissue.
(20 Mar 1998)
secondary lysosome <cell biology> Term used to describe intracellular vacuoles formed by the fusion of lysosomes with organelles (autosomes) or with primary phagosomes. Residual bodies are the remnants of secondary lysosomes containing indigestible material.
Origin: Gr. Soma = body
(18 Nov 1997)
secondary lysosomes Lysosome's in which lysis takes place, owing to the activity of hydrolytic enzymes; they are believed to eventually become residual bodies.
Synonym: definitive lysosomes, digestive vacuole.
(05 Mar 2000)
secondary medical care Medical care by a physician who acts as a consultant at the request of the primary physician.
(05 Mar 2000)
secondary megaureter Hydroureter secondary to vesicoureteral reflux or distal obstruction.
(05 Mar 2000)
secondary mesoderm Mesoderm derived from the primitive streak and lying between the ectoderm and endoderm.
Synonym: secondary mesoderm.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á